Sodium/potasium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: a new paradigm for development of anti- breast cancer drugs? Jin-Qiang ChenRuben G. ContrerasJose Russo Review 02 December 2005 Pages: 1 - 15
cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance David J. VilleneuveStacey L. HembruffAmadeo M. Parissenti OriginalPaper 02 December 2005 Pages: 17 - 39
Intensity modulated radiation therapy (IMRT) reduces the dose to the contralateral breast when compared to conventional tangential fields for primary breast irradiation Ajay K. BhatnagarEdward BrandnerDwight E. Heron Report 22 October 2005 Pages: 41 - 46
Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): a new type of mastectomy for breast cancer treatment Jean Yves PetitUmberto VeronesiChiara Casadio OriginalPaper 27 October 2005 Pages: 47 - 51
Prognostic factors for patients with liver metastases from breast cancer Michael H.R. EichbaumMargarete KaltwasserChristof Sohn Clinical trial 01 December 2005 Pages: 53 - 62
Cytosolic levels of TFF1/pS2 in breast cancer: their relationship with clinical–pathological parameters and their prognostic significance Maria D. CorteFrancisco TamargoF. Vizoso Clinical trial 03 November 2005 Pages: 63 - 72
Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer Ginelle C. GellertZ. Gunnur Dikmen Jerry W. Shay OriginalPaper 01 December 2005 Pages: 73 - 81
Serum biomarkers for detection of breast cancers: a prospective study Carole MathelinAnne CromerMarie- Christine Rio Clinical trial 02 December 2005 Pages: 83 - 90
PIK3CA mutations in breast cancer are associated with poor outcome Shao Ying LiMinna RongBarry Iacopetta Original Report 30 November 2005 Pages: 91 - 95
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer Valentina CalòValentina AgneseAntonio Russo Preclinical study 22 October 2005 Pages: 97 - 100
